Linagliptin and Metformin Hydrochloride Tablets(Ⅰ)

Boehringer Ingelheim (Schweiz) GmbH🇨🇳 National Medical Products Administration

Approval Id: 7MazXcUZi5y
Approval Number: H20170161
Generic Name: 利格列汀二甲双胍片(Ⅰ)
Generic Name En: Linagliptin and Metformin Hydrochloride Tablets(Ⅰ)
Trade Name: 欧双宁
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含利格列汀2.5 mg与盐酸二甲双胍500 mg
Reg Date: 2017-03-22
Expired Date: 2022-03-21
Company Name: Boehringer Ingelheim (Schweiz) GmbH
Company Address: Hochbergerstrasse 60B,4057 Basel, Switzerland
Production Company Name: Boehringer Ingelheim Pharma GmbH & Co. KG
Production Company Address: Binger Strasse 173, 55216 Ingelheim am Rhein, Germany
Company Detail Path: /organization/boehringer-ingelheim-schweiz-gmbh
Production Company Detail Path: /organization/boehringer-ingelheim-pharma-gmbh-and-co-kg

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 22, 2017

Approval ID

7MazXcUZi5y

Type

化学药品